NEW DELHI: The Union health ministry on Tuesday amended drug regulations to end the over-the-counter sale of syrup-based medicines, including cough syrups, making a doctor's prescription mandatory for ...

Arizona kids may no longer buy most kinds of over-the-counter cough and cold medicines unless they have a prescription. Arizona on Thursday became the fifth state in the country to enact a law ...

As one of the many biotech stocks investors are watching, Ocular Therapeutix focuses on treating retinal diseases. Its lead commercial product, Dextenza, is an insert for treating inflammation and ...

June 9 (Reuters) - Drug developer Parabilis Medicines is targeting a valuation of up to nearly $2.3 billion in its upsized initial public offering in the U.S., as biotech ‌IPOs continue to run hot.

Commercial support for your educational activity MUST be disclosed the participants of your educational activity. There are several methods of doing so, but printing it on promotional materials ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Myles is a former senior insurance editor for Investopedia. He oversaw the strategy ...

We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.